News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,146 Results
Type
Article (26151)
Company Profile (174)
Press Release (389806)
Multimedia
Podcasts (121)
Webinars (18)
Section
Business (122404)
Career Advice (1122)
Deals (27057)
Drug Delivery (123)
Drug Development (55607)
Employer Resources (90)
FDA (9438)
Job Trends (9506)
News (218671)
Policy (20366)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1090)
Accelerated approval (25)
Adcomms (24)
Allergies (102)
Alliances (32224)
ALS (122)
Alzheimer's disease (947)
Antibody-drug conjugate (ADC) (261)
Approvals (9686)
Artificial intelligence (426)
Autoimmune disease (133)
Automation (23)
Bankruptcy (220)
Best Places to Work (6929)
BIOSECURE Act (14)
Biosimilars (183)
Biotechnology (85)
Bladder cancer (91)
Brain cancer (48)
Breast cancer (355)
Cancer (3027)
Cardiovascular disease (299)
Career advice (948)
Career pathing (31)
CAR-T (157)
CDC (21)
Cell therapy (410)
Cervical cancer (25)
Clinical research (48847)
Collaboration (1320)
Company closure (2)
Compensation (435)
Complete response letters (59)
COVID-19 (1430)
CRISPR (64)
C-suite (648)
Cystic fibrosis (98)
Data (4182)
Decentralized trials (2)
Denatured (28)
Depression (103)
Diabetes (322)
Diagnostics (2896)
Digital health (29)
Diversity (10)
Diversity, equity & inclusion (28)
Drug discovery (231)
Drug pricing (209)
Drug shortages (33)
Duchenne muscular dystrophy (155)
Earnings (48927)
Editorial (54)
Employer branding (10)
Employer resources (88)
Events (57760)
Executive appointments (727)
FDA (11531)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (12)
Funding (897)
Gene editing (122)
Generative AI (42)
Gene therapy (366)
GLP-1 (916)
Government (2454)
Grass and pollen (4)
Guidances (282)
Healthcare (8404)
HIV (51)
Huntington's disease (29)
IgA nephropathy (71)
Immunology and inflammation (196)
Immuno-oncology (45)
Indications (98)
Infectious disease (1615)
Inflammatory bowel disease (149)
Inflation Reduction Act (12)
Influenza (71)
Intellectual property (178)
Interviews (161)
IPO (9302)
IRA (55)
Job creations (2793)
Job search strategy (811)
JPM (58)
Kidney cancer (11)
Labor market (65)
Layoffs (408)
Leadership (32)
Legal (5007)
Liver cancer (49)
Longevity (11)
Lung cancer (439)
Lymphoma (262)
Machine learning (31)
Management (33)
Manufacturing (664)
MASH (121)
Medical device (4638)
Medtech (4660)
Mergers & acquisitions (18663)
Metabolic disorders (1040)
mRNA (101)
Multiple sclerosis (125)
NASH (20)
Neurodegenerative disease (211)
Neuropsychiatric disorders (83)
Neuroscience (1852)
Neurotech (1)
NextGen: Class of 2026 (3244)
Non-profit (1531)
Now hiring (49)
Obesity (580)
Opinion (253)
Ovarian cancer (73)
Pain (172)
Pancreatic cancer (130)
Parkinson's disease (195)
Partnered (22)
Patents (353)
Patient recruitment (319)
Peanut (25)
People (38457)
Pharmaceutical (81)
Pharmacy benefit managers (34)
Phase 1 (15235)
Phase 2 (20753)
Phase 3 (16653)
Pipeline (4153)
Policy (250)
Postmarket research (1759)
Preclinical (5576)
Press Release (32)
Prostate cancer (164)
Psychedelics (32)
Radiopharmaceuticals (210)
Rare diseases (681)
Real estate (3697)
Recruiting (36)
Regulatory (16024)
Reports (32)
Research institute (1143)
Resumes & cover letters (187)
Rett syndrome (26)
RNA editing (12)
RSV (54)
Schizophrenia (137)
Series A (167)
Series B (108)
Service/supplier (9)
Sickle cell disease (74)
Special edition (23)
Spinal muscular atrophy (129)
Sponsored (21)
Startups (2442)
State (2)
Stomach cancer (13)
Supply chain (86)
Tariffs (96)
The Weekly (91)
Vaccines (560)
Venture capital (75)
Weight loss (412)
Women's health (55)
Worklife (11)
Date
Today (24)
Last 7 days (419)
Last 30 days (1651)
Last 365 days (18756)
2026 (3435)
2025 (19210)
2024 (21318)
2023 (23425)
2022 (31060)
2021 (32371)
2020 (30496)
2019 (25302)
2018 (19761)
2017 (20396)
2016 (19103)
2015 (22118)
2014 (17347)
2013 (14691)
2012 (15732)
2011 (16157)
2010 (14920)
Location
Africa (505)
Alabama (47)
Alaska (2)
Arizona (127)
Arkansas (11)
Asia (29638)
Australia (3982)
California (6163)
Canada (2209)
China (886)
Colorado (252)
Connecticut (278)
Delaware (230)
Europe (62384)
Florida (1074)
Georgia (151)
Hawaii (3)
Idaho (30)
Illinois (541)
India (62)
Indiana (382)
Iowa (7)
Japan (394)
Kansas (88)
Kentucky (35)
Louisiana (20)
Maine (14)
Maryland (765)
Massachusetts (4792)
Michigan (124)
Minnesota (297)
Mississippi (3)
Missouri (62)
Montana (18)
Nebraska (17)
Nevada (52)
New Hampshire (26)
New Jersey (2344)
New Mexico (22)
New York (1702)
North Carolina (1063)
North Dakota (4)
Northern California (2891)
Ohio (184)
Oklahoma (9)
Oregon (26)
Pennsylvania (1415)
Puerto Rico (22)
Rhode Island (35)
South America (757)
South Carolina (23)
Southern California (2557)
Tennessee (139)
Texas (875)
United States (23499)
Utah (140)
Vermont (1)
Virginia (202)
Washington D.C. (66)
Washington State (506)
West Virginia (3)
Wisconsin (73)
Wyoming (1)
416,146 Results for "addrenex pharmaceuticals acquired by sciele pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dexcel Pharma USA Acquires US Rights to Zubsolv®
January 8, 2026
·
1 min read
Press Releases
35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
February 25, 2026
·
5 min read
Patents
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
February 18, 2026
·
4 min read
·
Shawna Williams
Press Releases
PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use (“RTU”) Product Offering in the Hospital Market
January 7, 2026
·
4 min read
Press Releases
OKYO Pharma Announces Chairman and Founder Acquires Shares
November 24, 2025
·
1 min read
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
In this episode of Denatured, you’ll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.
February 26, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Press Releases
MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients
February 19, 2026
·
4 min read
Press Releases
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
November 5, 2025
·
10 min read
Press Releases
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
March 5, 2026
·
2 min read
1 of 41,615
Next
